Search results
New Products Posted to GenomeWeb: Qiagen QCI Software, Parse Biosciences Evercode BCR/TCR, More
GenomeWeb News· 2 days agoNew products and services posted to GenomeWeb for the week of April 29, 2024.
Cape DA pays $5,000 fine for pair of ethics violations after assuming office
The Republican· 4 days agoCape and Islands District Attorney Robert J. Galibois II paid a $5,000 civil penalty for violating...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Short Interest Update
ETF DAILY NEWS· 5 days agoActinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 1,980,000 ...
Aileron Therapeutics, Inc. (NASDAQ:ALRN) Major Shareholder Of Texas/Texas Am I. University Sells...
ETF DAILY NEWS· 4 days agoAileron Therapeutics, Inc. (NASDAQ:ALRN – Get Free Report) major shareholder Of Texas/Texas Am I. University sold 20,315 shares of Aileron Therapeutics stock in a transaction that occurred on ...
Cullinan Oncology (NASDAQ:CGEM) Now Covered by Stifel Nicolaus
ETF DAILY NEWS· 3 days agoAnalysts at Stifel Nicolaus initiated coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Get Free Report) in a report released on Wednesday, Marketbeat Ratings reports. The brokerage set ...
Syros Pharmaceuticals (NASDAQ:SYRS) Stock Price Passes Below 50 Day Moving Average of $5.94
ETF DAILY NEWS· 4 days agoSyros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Free Report)’s stock price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $5.94 ...
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Holdings Cut by Russell Investments Group Ltd.
ETF DAILY NEWS· 5 days agoRussell Investments Group Ltd. lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 84.5% during the fourth quarter, according to its most recent Form 13F filing with ...
Brokerages Set Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Price Target at $195.08
ETF DAILY NEWS· 5 days agoShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the thirteen ratings firms that are currently covering the ...
Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Re
Guru Focus· 2 days agoOn May 2, 2024, Shattuck Labs Inc (STTK, Financial), a trailblazer in bi-functional fusion protein technology, disclosed its financial outcomes for the first quarter ended March 31, 2024, through ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoReplay and MD Anderson announce FDA clearance of IND application for first-in-class PRAME-targeted T-Cell Receptor Natural Killer (TCR-NK) cell therapy for hematological malignancies Phase 1/2 study in patients with relapsed/refractory AML